China NMPA Product Recall - AT-1 consumables for C.A.T.S. autologous blood transfusion machine

The National Medical Products Administration (NMPA) issued a recall report concerning AT-1 Consumables for C.A.T.S. Autologous Blood Transfusion Machines, manufactured by Fresenius Kabi AG and managed in China by Fresenius Kabi (China) Investment Co., Ltd. The recall report, published on May 19, 2010, addressed a critical issue where the AT-1 consumables exhibited an "Alarm Blood Flow" phenomenon, causing the autologous blood transfusion machine to stop after pre-filling but before blood transfer could commence. This problem affected specific product batches, identified from YET151 to ZCT043. Although the company assessed that the issue posed "no direct harm to patients," Fresenius Kabi (China) initiated specific corrective actions under the NMPA's regulatory framework. These actions included notifying all users in writing, alerting customers to the potential malfunction, and clearly outlining the necessary corrective measures. Additionally, the company provided comprehensive training to users on these corrective procedures to ensure proper handling and mitigation of the issue. The implementation of these corrective actions was successfully completed by April 2010. This recall highlights the regulatory oversight by the NMPA in ensuring medical device safety and the manufacturer's responsibility in addressing product deficiencies promptly.